MedTrace Logo

Study of the Use of Misoprostol to Decrease Bleeding During a Myomectomy

NCT01700478 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2013-02-11

No results posted yet for this study

Summary

This study was done to determine if the use of a combination of preoperative rectal misoprostol 400µg used with intraoperative perivascular vasopressin is better than perivascular vasopressin used alone to decrease bleeding at myomectomy.

Conditions

Interventions

DRUG

Misoprostol + vasopressin

400ug of misoprostol is given per rectum, one hour prior to surgery. Vasopressin is used at the time of surgery.

DRUG

Vasopressin

Vasopressin was used in all patients during surgery.

Sponsors & Collaborators

  • University Hospital of the West Indies

    lead OTHER

Principal Investigators

  • Sharifa K Frederick, dM · University Hospital of the West Indies

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-02-28
Primary Completion
2005-04-30
Completion
2005-04-30

Countries

  • Jamaica

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01700478 on ClinicalTrials.gov